ClinConnect ClinConnect Logo
Search / Trial NCT06678568

The Optimized Follow-up Protocol for Pediatric Metaphyseal Forearm Fractures

Launched by NONTICHA THANTHONG · Nov 5, 2024

Trial Information

Current as of September 09, 2025

Not yet recruiting

Keywords

Metaphyseal Forearm Fracture Loss Of Reduction Follow Up Protocol Wrist Fracture

ClinConnect Summary

This clinical trial is studying the best way to follow up with children who have a specific type of wrist fracture called a displaced metaphyseal forearm fracture. The goal is to compare two different follow-up methods to see which one helps children heal better and have fewer complications. In this trial, children will be randomly assigned to one of two groups. One group will visit the hospital every week for four weeks to check their healing and have X-rays taken. The other group will also visit weekly, but during the third week, they will have a check-up using telemedicine, which means they can connect with their doctor online instead of going to the hospital.

To be eligible for this trial, children must be between 0 and 12 years old, have a wrist fracture that was seen at the hospital within 72 hours of the injury, and meet other specific conditions. It's important to note that children with certain complications, like open fractures or other serious injuries, won’t be included. If your child is eligible and participates, they can expect regular check-ins to monitor their healing, which will help doctors understand the best way to manage these types of fractures in the future.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Age 0-12 years
  • Patients with distal metaphyseal forearm fractures in Ramathibodi hospital and Chakri Naruebodindra Medical Institute
  • Presented to hospital within 72 hours of injury
  • Exclusion Criteria:
  • Open fracture
  • Operative treatment at 1st visit
  • Neurovascular injury
  • Polytraumatized patient
  • Ipsilateral fracture of upper limb
  • History of previous surgery in the affected arm
  • Metabolic bone disease

About Nonticha Thanthong

Nonticha Thanthong is a dedicated clinical trial sponsor committed to advancing medical research and improving patient outcomes. With a focus on innovative therapeutic interventions, Nonticha leads rigorous clinical studies that adhere to the highest ethical and regulatory standards. By fostering collaboration among healthcare professionals, researchers, and regulatory bodies, Nonticha strives to accelerate the development of safe and effective treatments. Their commitment to transparency and patient safety ensures that all trials are conducted with integrity, ultimately contributing to the enhancement of global health.

Locations

Ratchathewi, Bangkok, Thailand

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported